Answers are grounded in this paper and cite their sources.
Overall, our study revealed that METTL3, acting as an oncogene, maintained SOX2 expression through an m⁶A-IGF2BP2-dependent mechanism in CRC cells, and indicated a potential biomarker panel for prognostic prediction in CRC.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: